The Food and Drug Administration has approved a device that uses electrical stimulation to reduce inflammation from rheumatoid arthritis.

A team from Shriners Children's and Washington University in St. Louis are investigating a new method for personalizing ...

Results show that GLP-1s may address rheumatoid arthritis (RA) symptoms, independent of established weight loss and cardiac benefits, by reducing the systemic, chronic inflammation associated with RA.

Many people regard joint pain or stiffness as a natural phenomenon that occurs with age, but caution is needed because it may ...

A depleter of pathogenic T cells, rosnilimab’s novel MOA generated a differentiated efficacy, tolerability and safety profile ...